Monday, February 2, 2026

Microsoft: Analysts Anticipate Q4 Earnings Per Share Of $2.29

Microsoft (NASDAQ: MSFT) will be reporting its fiscal fourth quarter financials today after markets close. Analysts have a consensus $344 12-month price target on the company, via a total of 52 analysts, with 19 analysts having strong buy ratings. 30 analysts meanwhile have buy ratings and three analysts have hold ratings. The street high sits at a $426 price target, and the lowest target sits at $252.

24 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 24 analysts is $52.39 billion; this number is flat year to date now. The highest revenue estimate is $52.9 billion, while the lowest is $51.74 billion.

Onto EBITDA estimates, there are currently only six analysts who have fourth-quarter EBITDA estimates. The mean is currently $25.1 billion, with this number having been revised downwards from $25.4 billion at the start of the year. Street high is a $25.34 billion EBITDA estimate and the lowest is $24.88 billion.

Analysts estimate that quarterly earnings per share will come in at $2.29, with this number being revised steadily down since the start of the year. Street high is $2.35, and the lowest estimate is $2.24 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Related News

Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale

Antibe Therapeutics Inc. (TSX: ATE) recently reported their full-year 2022 results, wherein the company reported...

Friday, July 15, 2022, 02:25:00 PM

Microsoft Made Preparations to Absorb OpenAI’s Departing Staff — Except They Didn’t Leave

Microsoft (Nasdaq: MSFT) was getting ready to receive OpenAI employees who wanted to follow CEO...

Monday, November 27, 2023, 07:37:22 AM

Sundial Growers Expected To Post $13.88 Million In Q1 2021 Revenues

Sundial Growers Inc. (NASDAQ: SNDL) announced that they will be reporting their first quarter financials...

Tuesday, May 11, 2021, 02:11:00 PM

Bard Overboard: Why Microsoft Bing Finally Has A Chance In The Search Engine Race

The sudden ubiquity of AI-powered search has launched a tight race between the world’s tech...

Thursday, February 9, 2023, 09:14:00 AM

Ayr Wellness: Canaccord Raises Price Target To $70

On March 10th, Ayr Wellness (CSE: AYR.a) reported their fourth quarter and year end financial...

Sunday, March 14, 2021, 02:41:00 PM